|
Index of reports
> Cases resulting in death (28)
> Cases with Anaphylactic Reaction (7)
Below is the selection of adverse event reports related to Levaquin (Levofloxacin) that includes cases resulting in death where reactions include anaphylactic reaction.
Adverse event in 29 year old female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-20
Patient: 29 year old female, weighing 130.6 kg (287.3 pounds)
Adverse reactions / side effects: Cardiopulmonary Failure, Anaphylactic Reaction
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Start date: 2006-06-05
End date: 2006-06-05
Optiray 320
Start date: 2006-06-05
End date: 2006-06-05
Rocephin
Start date: 2006-06-05
End date: 2006-06-05
Other drugs received by patient: Demerol; Phenergan HCL; Sodium Chloride
Adverse event in 29 year old female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-25
Patient: 29 year old female, weighing 59.6 kg (131.2 pounds)
Adverse reactions / side effects: Asthma, Atelectasis, Urticaria, Anaphylactic Reaction, Blood PH Decreased, Pco2 Increased, PO2 Decreased, Cyanosis, Splenic Granuloma, Oedema, Pulmonary Oedema, Gallbladder Disorder, White Blood Cell Count Increased, Respiratory Rate Increased, Neutrophil Percentage Increased, Chest Discomfort, Blood Pressure Systolic Increased, Condition Aggravated, Local Swelling, Cholecystitis Chronic, Swollen Tongue, Electromechanical Dissociation, Heart Rate Increased, Respiratory Arrest, Basophil Percentage Increased, Ventricular Fibrillation, Cardiac Arrest, Lung Infiltration
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Dosage: 750 mg, single, intravenous
Indication: Abdominal Pain Lower
Start date: 2006-06-05
End date: 2006-06-05
Optiray 160
Dosage: 100 ml, single, intravenous
Indication: Computerised Tomogram Abdomen
Start date: 2006-06-05
End date: 2006-06-05
Rocephin
Dosage: 1 g, single, intravenous
Indication: Abdominal Pain Lower
Start date: 2006-06-05
End date: 2006-06-05
Other drugs received by patient: Sodium Chloride; Demerol; Phenergan / 00033001 / (Promethazine)
Adverse event in female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-09
Patient: female, weighing 130.6 kg (287.4 pounds)
Adverse reactions / side effects: Asthma, Cardiopulmonary Failure, Anaphylactic Reaction
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Indication: White Blood Cell Count Increased
Levaquin
Indication: Abdominal Pain Lower
Optiray 320
Indication: Abdomen Scan
Rocephin
Indication: White Blood Cell Count Increased
Rocephin
Indication: Abdominal Pain
Other drugs received by patient: Demerol; Phenergan HCL; Phenergan HCL; Sodium Chloride
Adverse event in female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-18
Patient: female, weighing 130.6 kg (287.4 pounds)
Adverse reactions / side effects: Asthma, Anaphylactic Reaction
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Indication: White Blood Cell Count Increased
Levaquin
Indication: Abdominal Pain
Optiray 320
Indication: Abdomen Scan
Rocephin
Indication: White Blood Cell Count Increased
Rocephin
Indication: Abdominal Pain
Adverse event in 29 year old female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-18
Patient: 29 year old female, weighing 130.6 kg (287.3 pounds)
Adverse reactions / side effects: Blood Pressure Systolic Increased, Cardiopulmonary Failure, Anaphylactic Reaction, Ventricular Fibrillation, Cardiac Arrest, Electromechanical Dissociation
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Start date: 2006-06-05
End date: 2006-06-05
Optiray 320
Start date: 2006-06-05
End date: 2006-06-05
Rocephin
Start date: 2006-06-05
End date: 2006-06-05
Other drugs received by patient: Demerol; Phenergan HCL; Sodium Chloride
Adverse event in 29 year old female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-04
Patient: 29 year old female, weighing 131.5 kg (289.3 pounds)
Adverse reactions / side effects: Neutrophil Percentage Increased, Atelectasis, Asthma, Anaphylactic Reaction, Pulmonary Oedema, Basophil Percentage Increased, Condition Aggravated, Gallbladder Oedema, White Blood Cell Count Increased
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Dosage: single, intravenous
Start date: 2006-06-05
End date: 2006-06-05
Optiray 320
Dosage: 100 ml, single, intravenous
Indication: Computerised Tomogram Abdomen
Start date: 2006-06-05
End date: 2006-06-05
Rocephin
Dosage: unk, single, intravenous
Start date: 2006-06-05
End date: 2006-06-05
Adverse event in 29 year old female receiving Levaquin (Levofloxacin)
Reported by a individual with unspecified qualification from United States on 2007-02-20
Patient: 29 year old female, weighing 131.5 kg (289.3 pounds)
Adverse reactions / side effects: Asthma, Atelectasis, Anaphylactic Reaction, Ventricular Fibrillation
Adverse event resulted in: death
Suspect drug(s):
Levaquin
Dosage: unk, single, intravenous
Start date: 2006-06-05
End date: 2006-06-05
Optiray 320
Dosage: 100 ml, single, intravenous
Indication: Computerised Tomogram Abdomen
Start date: 2006-06-05
End date: 2006-06-05
Rocephin
Dosage: unk, single, intravenous
Start date: 2006-06-05
End date: 2006-06-05
|
